Leica Microsystems will provide worldwide support and service for all Viventis Microscopy products from now on. Credit: Shutterstock/Aris-Tect Group.

Netherlands-based Aiosyn has extended the use of its AI-powered quality control (QC) software for digital pathology by upgrading its algorithms, so it is compatible with more types of slide staining.

The company’s AiosynQC solution now works with immunohistochemistry (IHC) slides, in addition to haematoxylin and eosin (H&E) slides.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The software is able to automatically flags areas in the specimen. By identifying the most common artefacts in histology images, the software ensures that pathologists, technicians and researchers only use high-quality images.

According to Aiosyn, the QC solution streamlines workflows by identifying problematic slides before they reach the pathologist and reducing the need for manual checking.

IHC staining is a backbone technique of pathology laboratories, with it being critical in diagnostic work and clinical research.

Digital pathology is a quickly growing area in healthcare. Hospitals are implementing the technology to allow greater throughput of tissue diagnosis and quicker turnaround times of analysis. Major companies such as Fujifilm and Roche are also entering the growing market.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Aiosyn chief technology officer David Tellez said: “Immunohistochemistry is an integral part of modern pathology practices, and we are excited to offer an AI-powered solution for QC compatible with IHC staining, empowering laboratories to further improve their pathology workflow.”

Separately in its portfolio, Aiosyn has also developed an AI tool to detect mitosis in whole slide images. By using deep learning, Mitosis-Breast can highlight mitotic figures in H&E slides. It is currently undergoing CE-mark certification under the EU in vitro medical device regulation.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact